galactosamine has been researched along with paclitaxel in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, XQ; Sun, TM; Wang, J; Wang, YC; Xiong, MH | 1 |
| Gupta, GK; Jain, V; Mishra, PR; Nath, B; Pant, AB; Shah, PP; Siddiqui, MA | 1 |
| Li, SS; Liu, C; Liu, ZP; Wu, JD; Zhang, CM | 1 |
| Banskota, AH; Kadota, S; Kurashige, Y; Le Tran, Q; Nguyen, NT; Nobukawa, T; Sasahara, M; Tezuka, Y | 1 |
4 other study(ies) available for galactosamine and paclitaxel
| Article | Year |
|---|---|
Functionalized micelles from block copolymer of polyphosphoester and poly(epsilon-caprolactone) for receptor-mediated drug delivery.
Topics: Antineoplastic Agents, Phytogenic; Asialoglycoprotein Receptor; Cell Cycle; Cell Line, Tumor; Cell Survival; Drug Carriers; Galactosamine; Glucosamine; Humans; Micelles; Paclitaxel; Polyesters; Polyethylenes | 2008 |
Galactose-grafted chylomicron-mimicking emulsion: evaluation of specificity against HepG-2 and MCF-7 cell lines.
Topics: Antineoplastic Agents, Phytogenic; Asialoglycoprotein Receptor; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Chylomicrons; Drug Delivery Systems; Emulsions; Female; Galactosamine; Galactose; Humans; Liver Neoplasms; Paclitaxel; Palmitic Acid; Particle Size | 2009 |
A branched small molecule-drug conjugate nanomedicine strategy for the targeted HCC chemotherapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Galactosamine; Hep G2 Cells; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; Mice, Nude; Molecular Structure; Nanomedicine; Paclitaxel; Small Molecule Libraries; Structure-Activity Relationship | 2022 |
Secoisolariciresinol and isotaxiresinol inhibit tumor necrosis factor-alpha-dependent hepatic apoptosis in mice.
Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; Butylene Glycols; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug Therapy, Combination; Furans; Galactosamine; Injections, Intraperitoneal; Interferon-gamma; Lignans; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred Strains; Phytotherapy; Plant Extracts; Plants, Medicinal; Taxus; Tumor Necrosis Factor-alpha | 2004 |